<?xml version="1.0" encoding="UTF-8"?>
<ref id="tbed13734-bib-0094">
 <mixed-citation publication-type="journal" id="tbed13734-cit-0094">
  <string-name>
   <surname>Xu</surname>, 
   <given-names>Z.</given-names>
  </string-name>, 
  <string-name>
   <surname>Peng</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Shi</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhu</surname>, 
   <given-names>Z.</given-names>
  </string-name>, 
  <string-name>
   <surname>Mu</surname>, 
   <given-names>K.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wang</surname>, 
   <given-names>X.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Zhu</surname>, 
   <given-names>W.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Nelfinavir was predicted to be a potential inhibitor of 2019‚ÄênCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation</article-title>. 
  <source xml:lang="en">BioRxiv</source>, Preprint. 
  <pub-id pub-id-type="doi">10.1101/2020.01.27.921627</pub-id>
 </mixed-citation>
</ref>
